COMP <GO>
SXI vs TMO // OPERATING MARGIN
Standex International Corporation (NYSE) VS. Thermo Fisher Scientific Inc (NYSE) • 15-METRIC TALLY: SXI 1
— TMO 9
▲ OPERATING MARGIN LEADER: TMO
LAST: $248.19 (+1.49%) • MKT CAP: $3.05B
operating-margins
11.80%
LAST: $709.18 (+0.71%) • MKT CAP: $262.22B
operating-margins
17.40%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (SXI VS. TMO)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | SXI | TMO | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 39.90% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 6.80% | 9.30% | -2.50 | TMO | /roic <GO> |
| EV/EBITDA & P/E Valuation | 36.2x | 30.4x | +5.80 | TMO | /valuation <GO> |
| Free Cash Flow Yield | 2.28% | 2.40% | -0.12 | TMO | /fcf-yield <GO> |
| Operating Margin ACTIVE | 11.80% | 17.40% | -5.60 | TMO | /operating-margins <GO> |
| Net Profit Margin | 7.30% | 15.10% | -7.80 | TMO | /net-margins <GO> |
| Revenue Growth (YoY) | — | 3.90% | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.49% | 0.24% | +0.25 | SXI | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | 4.50 | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 8/9 | -1.00 | TMO | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 39.2 | 62.9 | -23.70 | TMO | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 0.94 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 49.1x | 36.3x | +12.80 | TMO | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $3.05B | $262.22B | -$259.17B | TMO | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | SXI REV | TMO REV | SXI GROSS % | TMO GROSS % | SXI FCF | TMO FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $790.1M | $44.56B | 39.9% | — | $69.6M | $6.29B |
| FY 2024 | $720.6M | $42.88B | 39.1% | — | $92.7M | $7.27B |
| FY 2023 | $0 | $42.86B | — | — | $90.8M | $6.48B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
SXI // BETA —
TMO // BETA 0.94